Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!
What is the Expected Growth Rate of the Gastrointestinal Stromal Tumor Market from 2024 to 2033?
The gastrointestinal stromal tumor market has expanded rapidly, from $1.18 billion in 2023 to a projected $1.28 billion in 2024, showing a CAGR of 8.1%. Growth drivers include greater awareness and early diagnosis, advances in targeted therapies, improved surgical methods, development of personalized medicine, and better supportive care.
The gastrointestinal stromal tumor market is set to reach $1.69 billion by 2028, with a CAGR of 7.1%. The growth is attributed to continued research and drug development, a rise in patient-centric healthcare, the integration of precision medicine, better access to targeted therapies, and advancements in genomic profiling. Key trends include collaboration in research, developments in diagnostic technologies, focus on early detection, and the exploration of combination therapies.
Claim Your Free Sample of the Global Gastrointestinal Stromal Tumor Market Report Today!
https://www.thebusinessresearchcompany.com/sample.aspx?id=13248&type=smp
What Key Factors Are Fueling the Growth of the Gastrointestinal Stromal Tumor Market?
The increasing incidence of stomach cancer is anticipated to drive the growth of the gastrointestinal stromal tumor market. Stomach cancer, characterized by the uncontrolled growth of malignant cells, can lead to gastrointestinal stromal tumors (GISTs) in some cases. Cancer Research UK projected that stomach cancer incidence in the UK will decrease by 12% between 2023-2025 and 2038-2040, with 8 cases per 100,000 people annually. The rising prevalence of stomach cancer is expected to stimulate the demand for treatments related to gastrointestinal stromal tumors.
What Are the Major Segments of the Gastrointestinal Stromal Tumor Market?
1) By Treatment Type: Chemotherapy, Targeted Therapy, Other Treatment Types
2) By Indication: Stomach, Small Intestine, Others Indications
3) By End-User: Hospitals, Clinics, Specialized Cancer Treatment Centers, Other End-Users
What New Trends Are Transforming the Gastrointestinal Stromal Tumor Market?
In the gastrointestinal stromal tumor market, companies are focusing on developing new drugs like QINLOCK (Ripretinib) to expand their customer base and increase revenue. Zai Lab Ltd announced in March 2021 that the NMPA of China approved QINLOCK for treating advanced GIST. This drug is used to treat adult patients who have previously undergone treatment with three or more kinase inhibitors, offering a new option for GIST treatment.
Order Now for Fast Delivery of Your Gastrointestinal Stromal Tumor Market Report!
Which Regions Are Driving Growth in the Gastrointestinal Stromal Tumor Market?
North America was the largest region in the gastrointestinal stromal tumor market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal stromal tumor market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The Gastrointestinal Stromal Tumor Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the gastrointestinal stromal tumor market, its market share, and analyzes key competitors along with their market positions.
The Table Of Content For The Gastrointestinal Stromal Tumor Market Include
1. Gastrointestinal Stromal Tumor Market Executive Summary
2. Gastrointestinal Stromal Tumor Market Segments
3. Gastrointestinal Stromal Tumor Market Size And Template Market Growth Rate
4. Key Gastrointestinal Stromal Tumor Market Trends
5. Major Gastrointestinal Stromal Tumor Market Drivers
……
25. Key Mergers And Acquisitions In The Gastrointestinal Stromal Tumor Market
26. Top Gastrointestinal Stromal Tumor Companies
27. Gastrointestinal Stromal Tumor Market Opportunities And Strategies
28. Gastrointestinal Stromal Tumor Market, Conclusions And Recommendations
29. Appendix
Discover Related Reports by The Business Research Company:
Tumor Ablation Therapy Devices Global Market Report 2024
Tumor Embolization Devices Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/tumor-embolization-devices-global-market-report
Cancer Tumor Profiling Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/cancer-tumor-profiling-global-market-report
Learn More About The Business Research Company
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
